DUBLIN, Oct. 14, 2024 (Globe Newswire) — The “mRNA Cancer Vaccines and Therapeutics Market Report 2024” report has been added to ResearchAndMarkets.com’s offering.
The market size for mRNA cancer vaccines and therapeutics has grown rapidly in recent years. It is expected to grow from $52.85 billion in 2023 to $61.52 billion in 2024, at a compound annual growth rate (CAGR) of 16.4%. The market size of mRNA cancer vaccines and therapeutics is expected to grow rapidly in the coming years. It is expected to grow to $113.41 billion in 2028 at a compound annual growth rate (CAGR) of 16.5%.
The growth observed during this historic period is due to changes in lifestyles impacting medical needs, increased funding and investment support in medical research and development, a favorable regulatory environment that fosters innovation, and established establishments that support advances in treatments. This can be attributed to several factors, including the presence of a medical infrastructure. continued development of new therapeutic pipelines;
Growth over the forecast period is driven by promising results in clinical trials, increasing awareness and acceptance of mRNA technology in cancer treatment, significant unmet medical needs, potential for improved patient outcomes, and off-the-shelf therapeutics. This is likely due to the prospect of availability. . Key trends expected during this period include expansion into new therapeutic areas, utilization of personalized medicine approaches tailored to individual patient profiles, advancements in mRNA delivery systems to optimize efficacy and safety; These include the development of multivalent mRNA vaccines that target multiple antigens, and the integration of artificial intelligence and artificial intelligence. Machine learning in optimizing mRNA design to enhance therapeutic efficacy.
The increasing prevalence of cancer is expected to drive the growth of the mRNA cancer vaccines and therapeutics market in the coming years. Cancer includes a diverse group of diseases characterized by abnormal cell growth and invasion of healthy tissue due to the influence of factors such as a sedentary lifestyle, poor diet, and exposure to environmental toxins. Masu. mRNA cancer vaccines and therapeutics play an important role in cancer treatment by providing personalized, targeted therapies that enhance the immune system’s ability to identify and fight cancer cells, thereby increasing therapeutic efficacy. and improve patient outcomes.
Leading companies in the mRNA cancer vaccines and therapeutics market are committed to developing innovative treatments, particularly mRNA cancer vaccines, with the aim of increasing efficacy and addressing the growing demand for effective cancer treatments. I’m focusing on it. mRNA cancer vaccines use messenger RNA to instruct cells to produce specific antigens, which stimulate the immune system to recognize and target cancer cells.
For example, in May 2024, WestGene Biopharma, a China-based biotechnology company, received FDA approval for an investigational new drug application for its mRNA therapeutic cancer vaccine WGc-043. This development represents a significant advance in the treatment of aggressive EBV-associated cancers associated with a variety of malignancies, including nasopharyngeal cancer and NK T-cell lymphoma, as well as autoimmune diseases such as multiple sclerosis and lupus. I will.
The major companies operating in the mRNA cancer vaccines and therapeutics market are Pfizer, Merck, Bayer, Novartis SA, Sanofi, AstraZeneca, GlaxoSmithKline, Hoffman-La Roche, Eli Lilly and Company, Moderna Therapeutics. Inc., BioNTech SE, Regeneron Pharmaceuticals Inc., Catalent Inc., Sarepta Therapeutics Inc., Arcturus Therapeutics Holdings Inc., Genentech Inc., Immatics Biotechnologies GmbH, CureVac NV, Anima Biotech, Argos Therapeutics Inc.
North America was the largest region for the mRNA cancer vaccines and therapeutics market in 2023. Asia Pacific is expected to be the fastest growing region over the forecast period. The regions covered in the mRNA Cancer Vaccines and Therapeutics market report are Asia Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa. Countries covered in the mRNA Cancer Vaccines and Therapeutics market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, US, Canada, Italy, and Spain.
Competitive environment and company overview of the mRNA cancer vaccine and therapeutic drug market
Pfizer Inc. OverviewProducts and ServicesStrategyFinancial PerformanceMerck & Co Inc.Bayer AAGNovartis SASanofi AG
Other leading and innovative companies in the mRNA cancer vaccines and therapeutics market
AstraZeneca PlcGlaxoSmithKline PlcHoffmann-La Roche AGEli Lilly and CompanyModerna Therapeutics Inc.BioNTech SERegeneron Pharmaceuticals Inc.Catalent Inc.Sarepta Therapeutics Inc.Arcturus Therapeutics Holdings Inc.Genentech Inc.Immatic Biotechnologies GmbHCureVac N.VAnima BiotechArgos Therapeutics Inc
.Key attribute:
Report attribute details No. Number of pages 175 Forecast period 2024 – 2028 Estimated market value in 2024 (USD) 61.52 billion USD Predicted market value by 2028 (USD) 113.41 billion USD Average annual growth rate 16.5% Target region world
Main topics covered:
1. Summary
2. Characteristics of the mRNA cancer vaccine and therapeutic drug market
3. Trends and strategies in the mRNA cancer vaccine and therapeutic drug market
4. mRNA Cancer Vaccines and Therapeutics Market – Macroeconomic Scenario
4.1. Impact of high inflation on the market
4.2. Impact of the Ukraine-Russia war on the market
4.3. Impact of the new coronavirus infection on the market
5. Global mRNA cancer vaccine and therapeutic drug market size and growth
5.1.Global mRNA Cancer Vaccines and Therapeutics Market Driving and Constraining Factors
5.1.1. Market drivers
5.1.2. Market constraints
5.2. Global mRNA Cancer Vaccines and Therapeutics Market Historical Size and Growth, 2018-2023, Value ($ Billion)
5.3.Global mRNA Cancer Vaccines and Therapeutics Market Size and Growth Forecast, 2023-2028, 2033F, Value ($ Billion)
6. mRNA Cancer Vaccines and Therapeutics Market Segmentation
6.1. Global mRNA Cancer Vaccines and Therapeutics Market, Segmentation by Type, Historical and Forecast, 2018-2023, 2023-2028, 2033, $ Billion
adenocarcinomamucinous carcinomaadenosquamous carcinoma
6.2. Global mRNA Cancer Vaccines and Therapeutics Market, Segmentation by Application, Historical and Forecast, 2018-2023, 2023-2028, 2033, $ Billion
Infectious diseases Cancer and other uses
6.3. Global mRNA Cancer Vaccines and Therapeutics Market, Segmentation by End User, Historical and Forecast, 2018-2023, 2023-2028, 2033, $ Billion
Hospitals and Clinics Ambulatory Surgery Centers Research Institutions and Other End Users
7. Regional and country analysis of mRNA Cancer Vaccines and Therapeutics Market
7.1. Global mRNA Cancer Vaccines and Therapeutics Market, By Regions, Past and Forecast, 2018-2023, 2023-2028, 2033, $ Billion
7.2. Global mRNA Cancer Vaccines and Therapeutics Market, by Country, Historical and Forecast, 2018-2023, 2023-2028, 2033, $ Billion
For more information on this report, please visit https://www.researchandmarkets.com/r/9ptg77.
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world’s leading source of international market research reports and market data. We provide the latest data on international and regional markets, key industries, top companies, new products and latest trends.
mRNA cancer vaccines and therapeutics market
